Kyverna Therapeutics
KYTX · NASDAQ
$6.04+$0.21 (+3.60%)TodayMarket closed ·
Prev close $5.83
Who owns KYTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 54.2% of KYTX’s shares.
- VV Manager LLC7.9%
- Westlake Village BioPartners7.7%
- GordonMD Global Investments LP7.0%
- Gilead Sciences, Inc.6.8%
- Next 6 largest institutions24.9%
- All other shareholders45.8%
| Holder | Shares | % of shares |
|---|---|---|
| VV Manager LLC | 4.78M | 7.86% |
| Westlake Village BioPartners | 4.66M | 7.66% |
| GordonMD Global Investments LP | 4.24M | 6.98% |
| Gilead Sciences, Inc. | 4.13M | 6.79% |
| Northpond Ventures, LLC | 3.47M | 5.70% |
| Bain Capital Life Sciences Investors, LLC | 2.88M | 4.75% |
| BlackRock Institutional Trust Company, N.A. | 2.84M | 4.67% |
| AIGH Capital Management, LLC. | 2.07M | 3.41% |
| Deerfield Management Company, L.P. | 2.00M | 3.29% |
| Vanguard Capital Management, LLC | 1.90M | 3.12% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| MEDICAL BioHealth | 1.51M | 2.49% |
| Vanguard Total Stock Market Index Fund | 1.40M | 2.31% |
| iShares Russell 2000 ETF | 1.07M | 1.76% |
| T. Rowe Price Health Sciences Fund | 856.80K | 1.41% |
| Fidelity Enhanced Small Cap Core ETF | 470.97K | 0.77% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of KYTX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Aktar Mert | Award | 20.58K | — |
| Aktar Mert | Award | 5.09K | — |
| Shaw Christi | Tax withholding | 4.19K | $36.03K |
| Cohen Fred E | Award | 20.58K | — |
| Cohen Fred E | Award | 5.09K | — |
| CLARK IAN T | Award | 20.58K | — |
| CLARK IAN T | Award | 5.09K | — |
| SEIDENBERG BETH C | Award | 20.58K | — |
| SEIDENBERG BETH C | Award | 5.09K | — |
| Dac Nadia | Award | 300.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 9.62M
- Days to cover
- 8.85
- % of shares outstanding
- 15.82%
- Average daily volume
- 1.09M
- Change since last report
- +9.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.